Pharmacokinetics of dexmedetomidine in isoflurane-anesthetized New Zealand White rabbits

Research output: Contribution to journalArticle

Abstract

Objective To characterize the pharmacokinetics of dexmedetomidine when administered as a short intravenous (IV) infusion to isoflurane-anesthetized rabbits. Study design Experimental study. Animals A total of six healthy adult female New Zealand White rabbits. Methods Rabbits were anesthetized with isoflurane in oxygen. Following determination of isoflurane minimum alveolar concentration (MAC), the anesthetic dose was reduced to 0.7 × MAC, and dexmedetomidine hydrochloride (20 μg kg−1) was infused IV over 5 minutes. Arterial blood samples were obtained immediately before and at 1, 2, 5, 6, 7, 10, 15, 30, 60, 90, 120, 240 and 360 minutes following termination of the infusion. Samples were transferred into tubes containing ethylenediaminetetraacetic acid and centrifuged immediately. The plasma was harvested and stored at –80 °C until analyzed. Concentrations of dexmedetomidine in plasma were determined by liquid chromatography mass spectrometry. Compartment models were fitted to the time and concentration data using nonlinear regression. Results A three-compartment model best fit the data set. Median volume of distribution at steady state and terminal half-life were 3169 mL kg−1 (range, 2182–3859 mL kg−1) and 80 minutes (range, 72–88 minutes), respectively. Conclusions and clinical relevance The pharmacokinetics of dexmedetomidine in isoflurane-anesthetized, healthy, New Zealand White rabbits were characterized in this study. Data from this study can be used to determine dosing regimens for dexmedetomidine in isoflurane-anesthetized rabbits.

Original languageEnglish (US)
Pages (from-to)876-882
Number of pages7
JournalVeterinary Anaesthesia and Analgesia
Volume44
Issue number4
DOIs
StatePublished - Jul 1 2017

Fingerprint

dexmedetomidine
Dexmedetomidine
New Zealand White rabbit
Isoflurane
isoflurane
pharmacokinetics
Pharmacokinetics
Rabbits
rabbits
EDTA (chelating agent)
Intravenous Infusions
Edetic Acid
Liquid Chromatography
anesthetics
liquid chromatography
half life
Half-Life
Anesthetics
Mass Spectrometry
Research Design

Keywords

  • dexmedetomidine
  • isoflurane
  • rabbit
  • rabbit anesthesia

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Pharmacokinetics of dexmedetomidine in isoflurane-anesthetized New Zealand White rabbits. / Bailey, Ryan S.; Barter, Linda S; Pypendop, Bruno H.

In: Veterinary Anaesthesia and Analgesia, Vol. 44, No. 4, 01.07.2017, p. 876-882.

Research output: Contribution to journalArticle

@article{59cdc2b7c05546799525adf6e8cfc18f,
title = "Pharmacokinetics of dexmedetomidine in isoflurane-anesthetized New Zealand White rabbits",
abstract = "Objective To characterize the pharmacokinetics of dexmedetomidine when administered as a short intravenous (IV) infusion to isoflurane-anesthetized rabbits. Study design Experimental study. Animals A total of six healthy adult female New Zealand White rabbits. Methods Rabbits were anesthetized with isoflurane in oxygen. Following determination of isoflurane minimum alveolar concentration (MAC), the anesthetic dose was reduced to 0.7 × MAC, and dexmedetomidine hydrochloride (20 μg kg−1) was infused IV over 5 minutes. Arterial blood samples were obtained immediately before and at 1, 2, 5, 6, 7, 10, 15, 30, 60, 90, 120, 240 and 360 minutes following termination of the infusion. Samples were transferred into tubes containing ethylenediaminetetraacetic acid and centrifuged immediately. The plasma was harvested and stored at –80 °C until analyzed. Concentrations of dexmedetomidine in plasma were determined by liquid chromatography mass spectrometry. Compartment models were fitted to the time and concentration data using nonlinear regression. Results A three-compartment model best fit the data set. Median volume of distribution at steady state and terminal half-life were 3169 mL kg−1 (range, 2182–3859 mL kg−1) and 80 minutes (range, 72–88 minutes), respectively. Conclusions and clinical relevance The pharmacokinetics of dexmedetomidine in isoflurane-anesthetized, healthy, New Zealand White rabbits were characterized in this study. Data from this study can be used to determine dosing regimens for dexmedetomidine in isoflurane-anesthetized rabbits.",
keywords = "dexmedetomidine, isoflurane, rabbit, rabbit anesthesia",
author = "Bailey, {Ryan S.} and Barter, {Linda S} and Pypendop, {Bruno H}",
year = "2017",
month = "7",
day = "1",
doi = "10.1016/j.vaa.2017.01.003",
language = "English (US)",
volume = "44",
pages = "876--882",
journal = "Veterinary Anaesthesia and Analgesia",
issn = "1467-2987",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Pharmacokinetics of dexmedetomidine in isoflurane-anesthetized New Zealand White rabbits

AU - Bailey, Ryan S.

AU - Barter, Linda S

AU - Pypendop, Bruno H

PY - 2017/7/1

Y1 - 2017/7/1

N2 - Objective To characterize the pharmacokinetics of dexmedetomidine when administered as a short intravenous (IV) infusion to isoflurane-anesthetized rabbits. Study design Experimental study. Animals A total of six healthy adult female New Zealand White rabbits. Methods Rabbits were anesthetized with isoflurane in oxygen. Following determination of isoflurane minimum alveolar concentration (MAC), the anesthetic dose was reduced to 0.7 × MAC, and dexmedetomidine hydrochloride (20 μg kg−1) was infused IV over 5 minutes. Arterial blood samples were obtained immediately before and at 1, 2, 5, 6, 7, 10, 15, 30, 60, 90, 120, 240 and 360 minutes following termination of the infusion. Samples were transferred into tubes containing ethylenediaminetetraacetic acid and centrifuged immediately. The plasma was harvested and stored at –80 °C until analyzed. Concentrations of dexmedetomidine in plasma were determined by liquid chromatography mass spectrometry. Compartment models were fitted to the time and concentration data using nonlinear regression. Results A three-compartment model best fit the data set. Median volume of distribution at steady state and terminal half-life were 3169 mL kg−1 (range, 2182–3859 mL kg−1) and 80 minutes (range, 72–88 minutes), respectively. Conclusions and clinical relevance The pharmacokinetics of dexmedetomidine in isoflurane-anesthetized, healthy, New Zealand White rabbits were characterized in this study. Data from this study can be used to determine dosing regimens for dexmedetomidine in isoflurane-anesthetized rabbits.

AB - Objective To characterize the pharmacokinetics of dexmedetomidine when administered as a short intravenous (IV) infusion to isoflurane-anesthetized rabbits. Study design Experimental study. Animals A total of six healthy adult female New Zealand White rabbits. Methods Rabbits were anesthetized with isoflurane in oxygen. Following determination of isoflurane minimum alveolar concentration (MAC), the anesthetic dose was reduced to 0.7 × MAC, and dexmedetomidine hydrochloride (20 μg kg−1) was infused IV over 5 minutes. Arterial blood samples were obtained immediately before and at 1, 2, 5, 6, 7, 10, 15, 30, 60, 90, 120, 240 and 360 minutes following termination of the infusion. Samples were transferred into tubes containing ethylenediaminetetraacetic acid and centrifuged immediately. The plasma was harvested and stored at –80 °C until analyzed. Concentrations of dexmedetomidine in plasma were determined by liquid chromatography mass spectrometry. Compartment models were fitted to the time and concentration data using nonlinear regression. Results A three-compartment model best fit the data set. Median volume of distribution at steady state and terminal half-life were 3169 mL kg−1 (range, 2182–3859 mL kg−1) and 80 minutes (range, 72–88 minutes), respectively. Conclusions and clinical relevance The pharmacokinetics of dexmedetomidine in isoflurane-anesthetized, healthy, New Zealand White rabbits were characterized in this study. Data from this study can be used to determine dosing regimens for dexmedetomidine in isoflurane-anesthetized rabbits.

KW - dexmedetomidine

KW - isoflurane

KW - rabbit

KW - rabbit anesthesia

UR - http://www.scopus.com/inward/record.url?scp=85031107295&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85031107295&partnerID=8YFLogxK

U2 - 10.1016/j.vaa.2017.01.003

DO - 10.1016/j.vaa.2017.01.003

M3 - Article

C2 - 28655497

AN - SCOPUS:85031107295

VL - 44

SP - 876

EP - 882

JO - Veterinary Anaesthesia and Analgesia

JF - Veterinary Anaesthesia and Analgesia

SN - 1467-2987

IS - 4

ER -